Noninvasive and Dynamic Monitoring the Biological Parameters of Eyes in Different Age Groups
NCT ID: NCT05250440
Last Updated: 2022-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
240 participants
OBSERVATIONAL
2022-02-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In recent years, with the in-depth study of myopia, it is found that myopia is not only the change of diopter, but also the pathological changes of the whole eyeball shape and corresponding tissues. The incidence of myopia is closely related to the biological parameters of the eyeball, which has become a hotspot of clinical research in recent years. Current studies believe that eyeball biological parameters such as axial length, scleral thickness, choroid thickness are related to the occurrence of myopia, among which the change of scleral structure and shape, namely scleral remodeling, is considered to be an important factor in all visual stimuli leading to myopia. A large number of studies have also shown that scleral remodeling can lead to changes in the scleral biomechanics, thereby promoting the development of myopia. Multiple studies have shown a negative correlation between myopia and scleral thickness, with the thinning of the lower anterior sclera being the most significant. The lower anterior sclera is considered to be a marker for predicting the development of myopia, but some studies have found no correlation between the two. Such differences in the results may be related to the precision of the measurement instrument, the sample size of the included cases, age, and the grouping of different refractive states. The correlation between various biological parameters of the eyeball, especially the sclera, and myopia is not clear at present. Therefore, more penetrating and clearer instruments, more sample sizes, and more scientific grouping are needed for further research and confirmation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wuhan High Myopia Study
NCT06162234
Safety and Effectiveness of CARE1.02 Spectacle Lens in Myopia Control
NCT05818033
Zhaoqing Myopia Study
NCT04219228
The Evolutionary Model of Mild-to-moderate Myopia in China
NCT02667509
Development and Pathological Changes of High Myopia Among Children and Adolescents in China
NCT03533647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
(a1)Emmetropia: +0.75 to -0.75 D
age: 12 to 18 years old
No interventions assigned to this group
(a2)Mild myopia: -1.00 to -3.00 D
age: 12 to 18 years old
No interventions assigned to this group
(a3)Moderate myopia: -3.25 to -6.00 D
age: 12 to 18 years old
No interventions assigned to this group
(a4)High myopia: >-6.00 D
age: 12 to 18 years old
No interventions assigned to this group
(b1)Emmetropia: +0.75 to -0.75 D
age: 18 to 35 years old
No interventions assigned to this group
(b2)Mild myopia: -1.00 to -3.00 D
age: 18 to 35 years old
No interventions assigned to this group
(b3)Moderate myopia: -3.25 to -6.00 D
age: 18 to 35 years old
No interventions assigned to this group
(b4)High myopia: >-6.00 D
age: 18 to 35 years old
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No gender preference
* Healthy population aged between 12 and 35
Exclusion Criteria
* History of other eye diseases, surgery and/or medications, and eye trauma
* Anisometropia \> 2.00 D
* Astigmatism \> 2.00 D
* The best corrected visual acuity was less than 0.8
12 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhongnan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Min Ke, Doctor
Role: STUDY_DIRECTOR
Wuhan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022020901
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.